NP Life Sciences Health Industry Group Inc.

Overview

Compare with another stock.

• TickerACAT on OTC¹
• IndustryServices-Educational Services¹
• HeadquartersDanville, California¹
• Incorporated inNV²
• Business address4125 Blackhawk Plaza Circle, Suite 166, Danville, Ca 94506²
• Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company²

See how the biggest companies compare on our leaderboards

November 8, 2022, we formed our wholly-owned subsidiary GW Health Consulting Management Inc. ( “GW”), a California corporation. .³ From its latest annual report

Corporate structure

NP Life Sciences Health Industry Group Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What NP Life Sciences Health Industry Group Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

Leadership

Who has led NP Life Sciences Health Industry Group Inc., and when. Pick a name to see everywhere that person has worked.

• Chief executive officerSanjun Kuang Aug 4, 2020 to Aug 4, 2020¹²
• PresidentSanjun Kuang Aug 4, 2020 to Aug 4, 2020¹²

Former names

• GJ Culture Group US, Inc.Jul 9, 2019 to Sep 29, 2022²

Timeline

1. Sep 8, 20228-K Change in control; Executive or director change¹⁶
2. Dec 2, 20218-K Entered a material agreement¹⁷
3. Nov 1, 20218-K Entered a material agreement¹⁸
4. Aug 4, 2020New chief executive Sanjun Kuang becomes CEO¹²

Filings

26 filings to the SEC since October 2021: 3 annual reports, 7 quarterly reports, 3 major events, 2 insider forms, 2 large holders, 9 other. The latest 20:

1. Aug 21, 202415-12G EDGAR
2. May 15, 202415-12G EDGAR
3. Apr 16, 202410-K EDGAR
4. Apr 2, 2024NT 10-K EDGAR
5. Nov 14, 202310-Q EDGAR
6. Aug 14, 202310-Q EDGAR
7. May 15, 202310-Q EDGAR
8. Apr 18, 202310-K EDGAR
9. Apr 3, 2023NT 10-K EDGAR
10. Nov 30, 2022DEF 14C EDGAR
11. Nov 14, 202210-Q EDGAR
12. Sep 29, 2022PRE 14C EDGAR
13. Sep 8, 20228-K EDGAR
14. Sep 2, 20223 EDGAR
15. Sep 2, 2022SC 13D EDGAR
16. Sep 2, 20223 EDGAR
17. Sep 2, 2022SC 13D EDGAR
18. Aug 15, 202210-Q EDGAR
19. May 23, 202210-Q EDGAR
20. May 17, 2022NT 10-Q EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• Guidong WangSC 13D, 1 filing Sep 2, 2022¹⁹
• Huaying ZhuSC 13D, 1 filing Sep 2, 2022²⁰

SEC filer profile

How NP Life Sciences Health Industry Group Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARNP Life Sciences Health Industry Group Inc.¹
• CIK0001781726
• Employer ID (EIN)83-2912878¹
• Filer statusNon-accelerated filer<br>smaller reporting company<br>emerging growth company¹
• Incorporated inNevada¹
• Fiscal year endsDecember 31¹
• Industry code (SIC)8200 Services-Educational Services¹
• SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance¹
• Business address4125 Blackhawk Plaza Circle, Suite 166, Danville, CA 94506¹
• Phone(925)-362-3169¹
• Shares outstanding42,959,574 as of Apr 15, 2024⁴
• Public float$0 as of Jun 30, 2023⁴
• On EDGAR sinceJul 9, 2019¹
• Filings59 in all: 10-Q (13), 3 (7), SC 13D (6), 10-K (5), 8-K (5), NT 10-K (4), NT 10-Q (3), 15-12G (2)¹
  All 18 form types

  CORRESP (2), EFFECT (2), S-1/A (2), UPLOAD (2), 8-A12G (1), D (1), DEF 14C (1), POS AM (1), PRE 14C (1), S-1 (1)

• Latest filingsAnnual report (10-K) Apr 16, 2024
  Quarterly report (10-Q) Nov 14, 2023
  Latest 8-K (8-K) Sep 8, 2022